KCR Pharmaceuticals Private Limited

KCR Pharmaceuticals Private Limited - pharma in Adoor, Kerala, India. Directors, charges & compliance details.
CIN U85300KL2020PTC062642 Incorporated 01 July 2020 ROC Ernakulam HQ Adoor, Kerala, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹5.95 Cr
▲ 145% YoY
Net profit · FY 2025
₹16.93 Lakh
Net margin 2.8%
EBITDA · FY 2025
₹26.98 Lakh
EBITDA margin 4.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About KCR Pharmaceuticals Private Limited

Data last updated:

KCR Pharmaceuticals Private Limited is a private limited company based in Adoor, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 July 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U85300KL2020PTC062642. Its GSTIN is 32AAICK1399M1Z4 (Kerala).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Cyriac Pappachan and Pappachan Skariah Kalayil.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nalanda No. 11/72 – A Near High School Junction, Adoor, Kerala, India – 691523.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.95 Cr, a growth of 145% compared to the previous year. For the same year it recorded a net profit of ₹16.93 Lakh (net margin 2.8%) and EBITDA of ₹26.98 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 93% over three years.

KCR Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-11-0000123).

Company details

CIN U85300KL2020PTC062642
Registration Number 062642
Incorporation Date 01 July 2020
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KL-11-0000123

Recognitions & Rankings of KCR Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-KL-11-0000123

Contact details

KCR Pharmaceuticals Private Limited's registered office is in Adoor, Kerala.

  • Registered Address
    Nalanda No. 11/72 – A Near High School Junction, Adoor, Kerala, India – 691523
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
KCR Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of KCR Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of KCR Pharmaceuticals Private Limited, buy the company report.

Financials of KCR Pharmaceuticals Private Limited

FY 2025 filings available

KCR Pharmaceuticals Private Limited reported revenue of ₹5.95 Cr (up 145% YoY) for FY 2025.

Revenue · FY 2025
₹5.95 Cr ▲ 145%
Net profit · FY 2025
₹16.93 Lakh margin 2.8%
EBITDA · FY 2025
₹26.98 Lakh margin 4.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 145%
3 years · compounded
▲ 93%
EBITDA CAGR growth
1 year
▲ 183%
3 years · compounded
▲ 55%

Revenue has grown at a compounded annual rate (CAGR) of 93% over three years, including 145% growth in the latest year. EBITDA rose 183% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹26.98 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16.93 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.5%
Net Profit Margin2.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of KCR Pharmaceuticals Private Limited, buy the company report.

Board of directors of KCR Pharmaceuticals Private Limited

KCR Pharmaceuticals has 2 directors on record. No former directors are listed.

MSME payment delays

No delayed payments to MSME suppliers are on our record for KCR Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

KCR Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AAICK1399M1Z4KeralaActive22 Jul 2020

To see the full GST registrations and return filing status of KCR Pharmaceuticals Private Limited, buy the company report.

Recent activity

KCR Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Cyriac Pappachan was appointed as Director on 01 Jul 2020.

AGM
Kcr Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kcr Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Appointed
Cyriac Pappachan was appointed as Director.
Appointed
Pappachan Skariah Kalayil was appointed as Director.
Incorporation
01 Jul 2020
Kcr Pharmaceuticals Private Limited was registered on 01 Jul 2020 with Roc Ernakulam & aged 6 years 4 months as per MCA records.

Frequently asked questions

KCR Pharmaceuticals is an active private limited company based in Adoor, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 July 2020 (6+ years old) and is registered under CIN U85300KL2020PTC062642.

KCR Pharmaceuticals has 2 current directors:

The latest financial statements of KCR Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of KCR Pharmaceuticals is 32AAICK1399M1Z4, registered in Kerala.

The CIN (Corporate Identification Number) of KCR Pharmaceuticals is U85300KL2020PTC062642. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

KCR Pharmaceuticals was incorporated on 01 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ernakulam.

Cyriac Pappachan was appointed as Director on 01 Jul 2020. Pappachan Skariah Kalayil was appointed as Director on 01 Jul 2020.

Yes, KCR Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-11-0000123).

The registered office of KCR Pharmaceuticals is at Nalanda No. 1172 – A Near High School Junction, Adoor, Kerala, India – 691523.

KCR Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.